277
Participants
Start Date
February 22, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Fezolinetant
oral
Placebo
oral
Daido Clinic, Nagoya
Juno Vesta Clinic hatta, Matsudo-shi
Mori Ladies Clinic, Fukuoka
Kotoni Ladies Clinic, Sapporo
M's Ladies Clinic, Sapporo
NISHIKAWA Women's Health Clinic, Sapporo
Motomachi Ladies Clinic, Yokohama
Women's Clinic LUNA Yokohama Motomachi, Yokohama
Chieko Yukika Lady's Clinic, Sendai
GyNet Medical Corporation Minamimorimachi Ladies' Clinic, Osaka
Ninomiya Ladies Clinic, Osaka
Rikako Ladies Clinic, Osaka
Tennoji Chihiro Women's Clinic, Osaka
Shimizu Ladies Clinic, Sakai-shi
jMOG Medical Corporation Tanabe Ladies' Clinic, Takatsuki-shi
Marunouchi no Mori Ladies Clinic, Chiyoda-ku
Ginza Yoshida Medical Clinic, Chuo-ku
Medical Corporation Asbo Tokyo Asbo Clinic, Chuo-ku
Medical Corp.SEIKOUKAI New Medical Research System Clinic, Hachioji-shi
Kichijyoji Ladies Clinic, Musashino-shi
Shimamura Memorial Hospital, Nerima-ku
Yukawa Women'S Clinic, Nishi-Tokyo-shi
Shimodaira Ladies Clinic, Suginami-ku
Medical Corporation Associa Tamacenter Ladies Clinic, Tama-Shi
Lead Sponsor
Astellas Pharma Inc
INDUSTRY